LIRAGLUTIDE (LIRAGLUTIDE)

**Product type:** Human Prescription Drug

**Active ingredient:** LIRAGLUTIDE

**Strength:** 6 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Cipla USA Inc.

**Marketing category:** ANDA (ANDA217590)

**Pharmacologic class:** GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]